Related Experiment Video
Updated: May 11, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
A genetic screen identifies TCF3/E2A and TRIAP1 as pathway-specific regulators of the cellular response to p53
Zdenek Andrysik1, Jihye Kim, Aik Choon Tan
1Howard Hughes Medical Institute & Department of Molecular, Cellular and Developmental Biology, University of Colorado at Boulder, Boulder, CO 80309, USA.
Abstract:
The p53 transcription factor participates in diverse cellular responses to stress, including cell-cycle arrest, apoptosis, senescence, and autophagy. The molecular mechanisms defining the ultimate outcome of p53 activation remain poorly characterized. We performed a genome-wide genetic screen in human cells to identify pathway-specific coregulators of the p53 target gene CDKN1A (p21), an inhibitor of cell-cycle progression, versus BBC3 (PUMA), a key mediator of apoptosis. Our screen identified numerous factors whose depletion creates an imbalance in the p21:PUMA ratio upon p53 activation. The transcription factor TCF3, also known as E2A, drives p21 expression while repressing PUMA across cancer cell types of multiple origins. Accordingly, TCF3/E2A depletion impairs the cell-cycle-arrest response and promotes apoptosis upon p53 activation by chemotherapeutic agents. In contrast, TRIAP1 is a specific repressor of p21 whose depletion slows down cell-cycle progression. Our results reveal strategies for driving cells toward specific p53-dependent responses.
Insights
Researchers identified key regulators of the p53 pathway, uncovering TCF3/E2A and TRIAP1. Their findings offer strategies to direct p53-activated cells towards specific outcomes like cell-cycle arrest or apoptosis.
Area of Science:
- Molecular Biology
- Cellular Stress Response
- Cancer Biology
Background:
- The p53 transcription factor orchestrates critical cellular responses to stress, including cell-cycle arrest and apoptosis.
- The precise molecular mechanisms dictating the specific outcome of p53 activation remain incompletely understood.
- Understanding these mechanisms is crucial for developing targeted cancer therapies.
Purpose of the Study:
- To identify novel pathway-specific coregulators of p53 target genes.
- To differentiate regulators controlling cell-cycle arrest (p21) versus apoptosis (PUMA).
- To elucidate strategies for manipulating p53-dependent cellular fate.
Main Methods:
- Genome-wide genetic screen in human cells to identify p53 pathway coregulators.
- Analysis of factors influencing the ratio of p21 (CDKN1A) to PUMA (BBC3) expression.
- Functional assessment of identified factors (TCF3/E2A, TRIAP1) on p53-mediated cellular responses.
Main Results:
- The transcription factor TCF3 (E2A) was identified as a driver of p21 expression and a repressor of PUMA across various cancer cell types.
- Depletion of TCF3/E2A impairs p53-induced cell-cycle arrest and enhances apoptosis.
- TRIAP1 was identified as a specific repressor of p21, and its depletion slows cell-cycle progression.
Conclusions:
- TCF3/E2A and TRIAP1 are critical regulators that balance p53-mediated cell-cycle arrest and apoptosis.
- The study reveals specific molecular strategies to steer p53-activated cells towards desired outcomes.
- These findings have implications for designing therapies that selectively induce cell-cycle arrest or apoptosis in cancer cells.
More Related Videos
11:32Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter
Published on: March 27, 2020
08:49Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries
Published on: January 22, 2019
Related Concept Videos
Abnormal Proliferation
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Negative Regulator Molecules
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway
DNA Damage Can Stall the Cell Cycle